Navigation Links
A second career for a growth factor receptor: keeping nerve axons on target
Date:9/11/2008

LA JOLLA, CA Neurons constituting the optic nerve wire up to the brain in a highly dynamic way. Cell bodies in the developing retina sprout processes, called axons, which extend toward visual centers in the brain, lured by attractive cues and making U-turns when they take the wrong path. How they find targets so accurately is a central question of neuroscience today.

Using the mouse visual system, a team of Salk Institute for Biological Studies investigators led by Dennis O'Leary, Ph.D., identified an unanticipated factor that helps keep retinal axons from going astray. They report in the Sept. 11 issue of Neuron that p75, a protein previously known to regulate whether neurons live or die, leads a double life as an axon guidance protein.

"Historically, we thought that factors that mediate cell survival and those controlling axon guidance were part of two separate processes," says O'Leary, a professor in the Molecular Neurobiology Laboratory, "But in this study we show a direct interaction between these two systems."

Collaborating with Kuo-Fen Lee, Ph.D., professor in the Clayton Foundation Laboratories for Peptide Biology, the O'Leary team observed a defect in mice genetically engineered to lack p75. Through their synaptic connections, retinal axons develop a two-dimensional map of the retina in their targets in the brain. In the mice lacking p75, retinal axons stopped short of their final target and formed a map that was shifted forward to the superior colliculus, a major visual center in the brain.

Such a defect in p75-null mice was puzzling: researchers have studied p75 for decades and found it associated with activities as varied as neuronal growth, survival, and degeneration. Axonal migration was not among them.

Todd McLaughlin, Ph.D., a senior research associate in the lab and co-first author, says that insight came in a eureka moment: "We realized that what we were observing in these mice was s
'/>"/>

Contact: Gina Kirchweger
kirchweger@salk.edu
858-453-4100 x1340
Salk Institute
Source:Eurekalert  

Page: 1 2 3

Related biology news :

1. 60 second test could help early diagnosis of common brain diseases
2. BIO-key Reports Second Quarter 2007 Results
3. Communication Intelligence Corporation Reports Second Quarter 2007 Financial Results
4. Weight gain between first and second pregnancies associated with increased odds of male second child
5. Decisions on the second round of the Excellence Initiative announced
6. Second genetic link to weight and obesity
7. A new analysis method allows to find out the sex of the baby from the second month of pregnancy
8. Second Life a first for UH department of health and human performance
9. BIO-key(R) Reports Profitability on Strong Revenue Growth for Second Quarter 2008
10. L-1 Identity Solutions to Hold Supplemental Second Quarter 2008 Financial Results Q&A Conference Call at 2:00p.m. (ET) Today
11. TORC at UH turns to virtual world of Second Life for new study

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
A second career for a growth factor receptor: keeping nerve axons on target
A second career for a growth factor receptor: keeping nerve axons on target
(Date:11/9/2009)...s have had their hands tied because more than half...a protein called p53. As a critical anti-cancer wa...erations within cells. When cells lose p53, tumors..., These tumors might be tough, but they,re not in...rbor Laboratory (CSHL). The chink in the tumors, a...
(Date:11/9/2009)...has inspired a 3.2m, three-year research project t...f security, energy and the environment. The Univer...y QinetiQ have just signed a collaborative contrac...ing physical sciences research. , Over the next...ity of Exeter and QinetiQ will work together to de...
(Date:11/9/2009)...utritionist whose research was instrumental in add...fants and Children (WIC) food subsidy will receive...nding achievement in the field of maternal-fetal n...fessor in the Department of Community Health Scien...chool of Public Health, will receive the award to...
Breaking Biology News(10 mins):CSHL study shows that some malignant tumors can be shut down after all 2CSHL study shows that some malignant tumors can be shut down after all 3£3.2m ($5.4 million) research project to capture brilliance of butterfly wings 2March of Dimes honors Dr. Gail Harrison for outstanding work in maternal-fetal nutrition 2Rep Lewis Commends Kidney Care Partners Health Care Campaign to Improve Survival Rates of First Year Dialysis Patients in Georgia 48216 1Rep Lewis Commends Kidney Care Partners Health Care Campaign to Improve Survival Rates of First Year Dialysis Patients in Georgia 48216 2Rep Lewis Commends Kidney Care Partners Health Care Campaign to Improve Survival Rates of First Year Dialysis Patients in Georgia 48216 3VA Awards 243 7 Million for New Hampshire Veterans Home 48212 1HMS Holdings Corp to Present at William Blair 29th Annual Growth Stock Conference 48209 1
... have discovered that even the gruesome and brutal...ing jumping spider indigenous to East Africa, cant...ra no matter what the costs. A study recently publ...risk of sexual cannibalism, virgin females were at...y before opting for the safer smaller male as a lo...
...OMERVILLE, Mass. -- A new study by biologists at T... behind the magical light shows put on by fireflie...eriments to explore the potential costs of firefly... some surprising answers. , The research, to be ...aturalist and now available online ( http://www.jo...
...nian scientist and colleague report that a potenti...d to several countries is now established and repr...ris mud crabs are reproducing in the small, man-ma...s in Panamas new $5 billion canal expansion projec...nian Tropical Research Institute in Panama, and Do...
Other Biology News:The best both of worlds -- how to have sex and survive 2Biologists expose hidden costs of firefly flashes 2Biologists expose hidden costs of firefly flashes 3Smithsonian identifies invasive crab species in Panama Canal expansion area 2
(Date:11/6/2009)...TEO, Calif., Nov. 6 ,... transfer of Qutenza(TM) E.U. Marketing Authorizat...ant progress in commercial readiness activities E...r Director, Marketing; and Director, Commercial Op...s director and Audit Committee chairman , U...
(Date:11/6/2009)... The agenda for Arrowhead’s 201...hich is set to take place on February 22-24, 2010 ... day conference we will highlight key issues in fo... share their experiences. , ... agenda for Arrowhead’s 2010 Personalized M...
(Date:11/5/2009)...PANY, N.J., Nov. 5 DSM Pharmaceuti...nufacturing alliance with Galenix, Saint Jean D,Il...rcial scale manufacturing partner for Galenix comm...alenix will collaborate on business development op...hnologies, based on the strength of Galenix in dru...
(Date:11/5/2009)... Neb., Nov. 5 Transgenom...d financial results for the quarter ended Septembe...esented in the tables that follow. ,, Third Qu...of $366,000 or $0.01 per share for the third quart...r $0.01 per share for the third quarter of 2008. ...
Breaking Biology Technology:NeurogesX Reports Third Quarter 2009 Results 2NeurogesX Reports Third Quarter 2009 Results 3NeurogesX Reports Third Quarter 2009 Results 4NeurogesX Reports Third Quarter 2009 Results 5NeurogesX Reports Third Quarter 2009 Results 6NeurogesX Reports Third Quarter 2009 Results 7NeurogesX Reports Third Quarter 2009 Results 8NeurogesX Reports Third Quarter 2009 Results 9NeurogesX Reports Third Quarter 2009 Results 10Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 2Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 3DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 2DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 3Transgenomic, Inc. Reports Third Quarter 2009 Results 2Transgenomic, Inc. Reports Third Quarter 2009 Results 3Transgenomic, Inc. Reports Third Quarter 2009 Results 4Transgenomic, Inc. Reports Third Quarter 2009 Results 5Transgenomic, Inc. Reports Third Quarter 2009 Results 6Transgenomic, Inc. Reports Third Quarter 2009 Results 7
...co Pharmaceutical,Laboratories, Ltd. (Amex: CPD )...2009, ended June 30, 2008, of $108.3 million, as c...iod of Fiscal 2008. This represents an,increase of...ax income grew,to $14.6 million for the first quar... of $9.6 million during the corresponding period o...
...l Discuss Company,s IPLEX(TM) Program in Myotonic ...HMOND, Va., July 25 Insmed Inc. (Nasdaq:,INSM) a ...icals, today,announced that Geoffrey Allan, Ph.D.,...Drug Discovery and Development of Innovative Thera...T., Dr. Allan will be participating in the Orphan...
...%, ORANGE COUNTY, Calif., July 25 Beckman,Coulte...cturer and marketer,of products that simplify, aut...ounced today second quarter and first half ended J...ion increased 15.7% over second,quarter 2007. In c...gs were,$47.8 million, or $0.74 per fully diluted ...
Other Biology Technology:Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 2Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 3Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 4Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 5Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 6Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 7Insmed CEO to Present at Drug Discovery & Development Conference 2Beckman Coulter Announces Second Quarter 2008 Results 2Beckman Coulter Announces Second Quarter 2008 Results 3Beckman Coulter Announces Second Quarter 2008 Results 4Beckman Coulter Announces Second Quarter 2008 Results 5Beckman Coulter Announces Second Quarter 2008 Results 6Beckman Coulter Announces Second Quarter 2008 Results 7Beckman Coulter Announces Second Quarter 2008 Results 8Beckman Coulter Announces Second Quarter 2008 Results 9Beckman Coulter Announces Second Quarter 2008 Results 10Beckman Coulter Announces Second Quarter 2008 Results 11Beckman Coulter Announces Second Quarter 2008 Results 12Beckman Coulter Announces Second Quarter 2008 Results 13Beckman Coulter Announces Second Quarter 2008 Results 14Beckman Coulter Announces Second Quarter 2008 Results 15Beckman Coulter Announces Second Quarter 2008 Results 16Beckman Coulter Announces Second Quarter 2008 Results 17Beckman Coulter Announces Second Quarter 2008 Results 18Beckman Coulter Announces Second Quarter 2008 Results 19Beckman Coulter Announces Second Quarter 2008 Results 20Beckman Coulter Announces Second Quarter 2008 Results 21Beckman Coulter Announces Second Quarter 2008 Results 22Beckman Coulter Announces Second Quarter 2008 Results 23Beckman Coulter Announces Second Quarter 2008 Results 24Beckman Coulter Announces Second Quarter 2008 Results 25Beckman Coulter Announces Second Quarter 2008 Results 26Beckman Coulter Announces Second Quarter 2008 Results 27Beckman Coulter Announces Second Quarter 2008 Results 28
Customized Competent E. coli. from Molecular Cloning Laboratories (MCLAB)
Fluorescent Standards Red Standard from Invitrogen
X-Gal from GE Healthcare, formerly Amersham Biosciences
Mouse Anti-Oligodendrocyte Marker O1 Monoclonal Antibody, Unconjugated, Clone O1 from R&D Systems
Biology Products: